Literature DB >> 20025916

Efficient selection of IgG Fc domain-binding peptides fused to fluorescent protein using E. coli expression system and dot-blotting assay.

Yu-jin Jeong1, Hyo Jin Kang, Kwang-Hee Bae, Min-Gon Kim, Sang J Chung.   

Abstract

Antibody purification technology is of particular industrial importance due to the rapidly increasing use of antibodies in protein purification, diagnostic and therapeutic applications. Such purification has mostly relied on affinity chromatography using Protein A or Protein G as affinity ligands. Several synthetic ligands have also been developed to overcome the disadvantages associated with protein affinity ligands, which include high cost, low stability and possible contamination if the proteins have been expressed in bacteria. In the present study, a convenient selection method for new peptides binding to the IgG Fc domain was developed. The method includes the construction of a DNA library fused to the 5'-position of the eGFP gene expressed from a constitutive vector, expression of the library in Escherichia coli, fluorescence-based screening, and determination of the antibody-binding affinities of selected peptides using surface plasmon resonance. With this method, five novel peptides were identified as new affinity ligands for the IgG Fc domain, and the binding affinities were appropriate for antibody purification. This method is a convenient alternative to phage or bacterial surface display and can be used in the routine biochemistry laboratory. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025916     DOI: 10.1016/j.peptides.2009.12.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Artificial DnaJ Protein for protein production and conformational diseases.

Authors:  Akinori Hishiya; Keizo Koya
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

2.  Genetically engineering encapsulin protein cage nanoparticle as a SCC-7 cell targeting optical nanoprobe.

Authors:  Hyojin Moon; Jisu Lee; Hansol Kim; Somin Heo; Junseon Min; Sebyung Kang
Journal:  Biomater Res       Date:  2014-12-23

3.  A Recombinant Secondary Antibody Mimic as a Target-specific Signal Amplifier and an Antibody Immobilizer in Immunoassays.

Authors:  Junseon Min; Eun Kyung Song; Hansol Kim; Kyoung Taek Kim; Tae Joo Park; Sebyung Kang
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.